In the context of geroscience, chaperones are essential proteins that help other proteins achieve their correct shape and maintain their stability. This is particularly important because misfolded proteins can lead to cellular dysfunction and are associated with various age-related diseases. In dogs, as they age, the effectiveness of these chaperones can decline, potentially leading to health issues such as cognitive decline or degenerative diseases. Understanding how chaperones function can provide insights into how we might support canine health as our pets grow older. Research into geroscience has shown that enhancing the activity of chaperones may help mitigate some effects of aging in dogs, similar to findings in other species. For instance, compounds that boost chaperone activity could improve cellular resilience and longevity, potentially leading to healthier, more active lives for our canine companions. This area of study is still evolving, but it holds promise for developing interventions that could positively impact our pets' quality of life as they age.
GLOSSARY · GLOSSARY · GLOSSARY · GLOSSARY · GLOSSARY · GLOSSARY ·
Chaperones
Chaperones are proteins that assist in the proper folding and maintenance of other proteins, playing a critical role in cellular health and longevity.
Why it matters
For dog owners, supporting the health of chaperones may contribute to their pet's overall longevity and well-being.
Save this page and we'll email when the science updates
We email when there is real news, not before.
Keep exploring
breedSoft Coated Wheaten Terrier longevity briefglossaryGlossary: Akkermansia muciniphilanewsPre-launch dossier: what we know about the canine longevity pill in 2026blogThe microbiome and longevity: a careful look at the latest dog studiesmythMyth vs fact: A cold nose indicates that a dog is healthy.newsGeroscience consortium adds three more breeds to dose-finding studybreedSpanish Mastiff longevity briefmythMyth vs fact: All antioxidants are equally potent.newsEU agency confirms it will publish a guidance document this quarterblogWhy country comparisons of pill rollout are usually wrongbreedParson Russell Terrier longevity briefblogHow biomarker panels will define longevity protocols by 2030